Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Prospect Capital announces results of cash tender offer for Senior Notes » 08:02
11/21/22
11/21
08:02
11/21/22
08:02
PSEC

Prospect Capital

$7.62 /

+0.055 (+0.73%)

Prospect Capital…

Prospect Capital Corporation announced the results of its previously announced cash tender offer to purchase any and all of the outstanding notes listed below. The Tender Offer was made pursuant to an Offer to Purchase dated November 14, 2022 which set forth the terms and conditions of the Tender Offer. As of the previously announced expiration time of 5:00 p.m., New York City time, on November 18, 2022 according to information provided by D.F. King & Co., Inc., the information and tender agent for the Tender Offer, a total of $249,000 aggregate principal amount of Notes had been validly tendered and not validly withdrawn in the Tender Offer. Withdrawal rights for the Notes expired at 5:00 p.m., New York City time, on November 18, 2022. The table below sets forth the aggregate principal amount and percentage of the Notes validly tendered and not validly withdrawn by the Expiration Time that will be accepted for purchase by the Company.The consideration to be paid for the Eligible Notes is $987.50 for each $1,000 principal amount of Eligible Notes, plus accrued and unpaid interest on the Eligible Notes, if any, from the applicable last interest payment date up to, but not including, the settlement date, which date is expected to be November 23, 2022.

ShowHide Related Items >><<
PSEC Prospect Capital
$7.62 /

+0.055 (+0.73%)

PSEC Prospect Capital
$7.62 /

+0.055 (+0.73%)

PSEC Prospect Capital
$7.62 /

+0.055 (+0.73%)

Over a quarter ago
Hot Stocks
Prospect Capital announces results of cash tender offer for Senior Notes » 07:25
10/24/22
10/24
07:25
10/24/22
07:25
PSEC

Prospect Capital

$6.96 /

+0.095 (+1.38%)

Prospect Capital…

Prospect Capital Corporation announced the results of its previously announced cash tender offer to purchase any and all of the outstanding notes. The Tender Offer was made pursuant to an Offer to Purchase dated October 17, 2022 which set forth the terms and conditions of the Tender Offer. As of the previously announced expiration time of 5:00 p.m., New York City time, on October 21, 2022, according to information provided by D.F. King & Co., Inc., the information and tender agent for the Tender Offer, a total of $1,508,000 aggregate principal amount of Notes had been validly tendered and not validly withdrawn in the Tender Offer. Withdrawal rights for the Notes expired at 5:00 p.m., New York City time, on October 21, 2022. The consideration to be paid for the Eligible Notes is $985.00 for each $1,000 principal amount of Eligible Notes, plus accrued and unpaid interest on the Eligible Notes, if any, from the applicable last interest payment date up to, but not including, the settlement date, which date is expected to be October 26, 2022.

ShowHide Related Items >><<
PSEC Prospect Capital
$6.96 /

+0.095 (+1.38%)

PSEC Prospect Capital
$6.96 /

+0.095 (+1.38%)

11/09/21 Raymond James
Prospect Capital upgraded to Market Perform from Underperform at Raymond James
11/09/21 Raymond James
Prospect Capital upgraded to Market Perform from Underperform at Raymond James
PSEC Prospect Capital
$6.96 /

+0.095 (+1.38%)

PSEC Prospect Capital
$6.96 /

+0.095 (+1.38%)

Hot Stocks
Prospect Capital announces launch of cash tender offer » 08:51
10/17/22
10/17
08:51
10/17/22
08:51
PSEC

Prospect Capital

$6.67 /

-0.04 (-0.60%)

Prospect Capital…

Prospect Capital Corporation announced that it has commenced a cash tender offer to purchase any and all of the outstanding notes listed below. The Tender Offer will expire at 5:00 p.m., New York City time, on October 21, 2022, or any other date and time to which the Company extends the Tender Offer. The Tender Offer is made pursuant to an Offer to Purchase dated today and related notice of guaranteed delivery, which set forth the terms and conditions of the Tender Offer. The consideration to be paid for each $1,000 principal amount of Notes that are validly tendered and not validly withdrawn on or prior to the Expiration Time is $985.00, plus accrued and unpaid interest on the Notes, if any, from the applicable last interest payment date up to, but not including, the Settlement Date. The Company will purchase any Notes that have been validly tendered at or prior to the Expiration Time and accepted for purchase, subject to all conditions to the Tender Offer having been either satisfied or waived by the Company, promptly following the Expiration Time. Assuming the Tender Offer is not extended, the Company expects that the Tender Offer will settle and payment will be made on October 26, 2022.

ShowHide Related Items >><<
PSEC Prospect Capital
$6.67 /

-0.04 (-0.60%)

PSEC Prospect Capital
$6.67 /

-0.04 (-0.60%)

11/09/21 Raymond James
Prospect Capital upgraded to Market Perform from Underperform at Raymond James
11/09/21 Raymond James
Prospect Capital upgraded to Market Perform from Underperform at Raymond James
PSEC Prospect Capital
$6.67 /

-0.04 (-0.60%)

PSEC Prospect Capital
$6.67 /

-0.04 (-0.60%)

Options
Largest borrow rate increases among liquid names » 08:45
10/14/22
10/14
08:45
10/14/22
08:45
BCTX

BriaCell

$6.57 /

+0.26 (+4.12%)

, BKLN

Invesco Senior Loan ETF

$20.48 /

+0.015 (+0.07%)

, TIGR

UP Fintech

$3.30 /

-0.02 (-0.60%)

, TRQ

Turquoise Hill

$29.49 /

+0.29 (+0.99%)

, VOO

Vanguard S&P 500 ETF

$336.36 /

+8.63 (+2.63%)

, BBBY

Bed Bath & Beyond

$5.16 /

-0.11 (-2.09%)

, AEVA

Aeva Technologies

$1.95 /

+0.045 (+2.36%)

, PSEC

Prospect Capital

$6.71 /

+0.18 (+2.76%)

, GRWG

GrowGeneration

$3.50 /

+0.06 (+1.74%)

, EZU

iShares MSCI Eurozone ETF

$32.80 /

+0.92 (+2.89%)

Latest data shows the…

Latest data shows the largest indicative borrow rate increases among liquid option names include: BriaCell Therapeutics (BCTX) 27.97% +0.90, Powershares Loan ETF (BKLN) 17.34% +0.44, UP Fintech Holding Ltd (TIGR) 36.42% +0.24, Turquoise Hill (TRQ) 0.78% +0.18, Vanguard S&P 500 (VOO) 0.35% +0.10, Bed Bath & Beyond (BBBY) 9.96% +0.10, Aeva Technologies (AEVA) 1.01% +0.09, Prospect Capital (PSEC) 4.13% +0.09, Growgeneration (GRWG) 1.11% +0.09, and iShares Emu Index (EZU) 1.17% +0.08.

ShowHide Related Items >><<
TRQ Turquoise Hill
$29.49 /

+0.29 (+0.99%)

TIGR UP Fintech
$3.30 /

-0.02 (-0.60%)

PSEC Prospect Capital
$6.71 /

+0.18 (+2.76%)

GRWG GrowGeneration
$3.50 /

+0.06 (+1.74%)

BCTX BriaCell
$6.57 /

+0.26 (+4.12%)

BBBY Bed Bath & Beyond
$5.16 /

-0.11 (-2.09%)

AEVA Aeva Technologies
$1.95 /

+0.045 (+2.36%)

BCTX BriaCell
$6.57 /

+0.26 (+4.12%)

02/14/22 H.C. Wainwright
BriaCell initiated with a Buy at H.C. Wainwright
BKLN Invesco Senior Loan ETF
$20.48 /

+0.015 (+0.07%)

TIGR UP Fintech
$3.30 /

-0.02 (-0.60%)

06/13/22 Daiwa
UP Fintech price target raised to $5.70 from $5.40 at Daiwa
05/19/22 China Renaissance
UP Fintech assumed with Hold from Buy at China Renaissance
12/01/21 Citi
UP Fintech price target lowered to $7.58 from $18.22 at Citi
10/29/21 Alliance Global Partners
MICT could benefit on top China brokers' fallout, says Alliance Global Partners
TRQ Turquoise Hill
$29.49 /

+0.29 (+0.99%)

10/13/22 Scotiabank
Turquoise Hill downgraded to Sector Perform from Outperform at Scotiabank
10/13/22 Canaccord
Turquoise Hill downgraded to Hold from Buy at Canaccord
09/06/22 Scotiabank
Mining may be on 'precipice of new M&A cycle,' says Scotiabank
08/25/22 TD Securities
Turquoise Hill price target raised to C$40 from C$34 at TD Securities
VOO Vanguard S&P 500 ETF
$336.36 /

+8.63 (+2.63%)

BBBY Bed Bath & Beyond
$5.16 /

-0.11 (-2.09%)

09/30/22 Odeon Capital
Odeon upgrades Bed Bath & Beyond to Hold with things 'moving in right direction'
09/30/22 Odeon Capital
Bed Bath & Beyond upgraded to Hold from Sell at Odeon Capital
09/01/22 BofA
BofA cuts Bed Bath & Beyond target to $2 on continuing cash burn
09/01/22 Raymond James
Raymond James downgrades Bed Bath & Beyond to sell on 'abysmal' trends
AEVA Aeva Technologies
$1.95 /

+0.045 (+2.36%)

07/18/22 Piper Sandler
Aeva Technologies downgraded to Neutral from Overweight at Piper Sandler
04/14/22 Credit Suisse
Aeva Technologies initiated with an Outperform at Credit Suisse
01/24/22 Craig-Hallum
Aeva Technologies price target lowered to $10 from $15 at Craig-Hallum
01/13/22 Piper Sandler
Aeva Technologies price target lowered to $10 from $12 at Piper Sandler
PSEC Prospect Capital
$6.71 /

+0.18 (+2.76%)

11/09/21 Raymond James
Prospect Capital upgraded to Market Perform from Underperform at Raymond James
11/09/21 Raymond James
Prospect Capital upgraded to Market Perform from Underperform at Raymond James
GRWG GrowGeneration
$3.50 /

+0.06 (+1.74%)

08/05/22 Alliance Global Partners
GrowGeneration downgraded to Neutral from Buy at Alliance Global Partners
05/12/22 Oppenheimer
GrowGeneration price target lowered to $15 from $50 at Oppenheimer
05/11/22 Wells Fargo
GrowGeneration price target lowered to $4 from $8 at Wells Fargo
05/11/22 Alliance Global Partners
GrowGeneration price target lowered to $7 from $14 at Alliance Global
EZU iShares MSCI Eurozone ETF
$32.80 /

+0.92 (+2.89%)

TRQ Turquoise Hill
$29.49 /

+0.29 (+0.99%)

PSEC Prospect Capital
$6.71 /

+0.18 (+2.76%)

GRWG GrowGeneration
$3.50 /

+0.06 (+1.74%)

BBBY Bed Bath & Beyond
$5.16 /

-0.11 (-2.09%)

AEVA Aeva Technologies
$1.95 /

+0.045 (+2.36%)

BBBY Bed Bath & Beyond
$5.16 /

-0.11 (-2.09%)

TRQ Turquoise Hill
$29.49 /

+0.29 (+0.99%)

GRWG GrowGeneration
$3.50 /

+0.06 (+1.74%)

BBBY Bed Bath & Beyond
$5.16 /

-0.11 (-2.09%)

AEVA Aeva Technologies
$1.95 /

+0.045 (+2.36%)

TRQ Turquoise Hill
$29.49 /

+0.29 (+0.99%)

TIGR UP Fintech
$3.30 /

-0.02 (-0.60%)

PSEC Prospect Capital
$6.71 /

+0.18 (+2.76%)

GRWG GrowGeneration
$3.50 /

+0.06 (+1.74%)

BKLN Invesco Senior Loan ETF
$20.48 /

+0.015 (+0.07%)

BCTX BriaCell
$6.57 /

+0.26 (+4.12%)

BBBY Bed Bath & Beyond
$5.16 /

-0.11 (-2.09%)

VOO Vanguard S&P 500 ETF
$336.36 /

+8.63 (+2.63%)

Hot Stocks
Prospect Capital announces results of cash tender offer for Senior Notes » 07:07
09/26/22
09/26
07:07
09/26/22
07:07
PSEC

Prospect Capital

$6.78 /

-0.11 (-1.60%)

Prospect Capital…

Prospect Capital announced the results of its previously announced cash tender offer to purchase any and all of the outstanding notes listed below. The Tender Offer was made pursuant to an Offer to Purchase dated September 19, 2022, which set forth the terms and conditions of the Tender Offer. As of the previously announced expiration time of 5:00 p.m., New York City time, on September 23, 2022, according to information provided by D.F. King & Co., Inc., the information and tender agent for the Tender Offer, a total of $347,000 aggregate principal amount of Notes had been validly tendered and not validly withdrawn in the Tender Offer. Withdrawal rights for the Notes expired at 5:00 p.m., New York City time, on September 23, 2022. The consideration to be paid for the Eligible Notes is $980.00 for each $1,000 principal amount of Eligible Notes, plus accrued and unpaid interest on the Eligible Notes, if any, from the applicable last interest payment date up to, but not including, the settlement date, which date is expected to be September 28, 2022.

ShowHide Related Items >><<
PSEC Prospect Capital
$6.78 /

-0.11 (-1.60%)

PSEC Prospect Capital
$6.78 /

-0.11 (-1.60%)

11/09/21 Raymond James
Prospect Capital upgraded to Market Perform from Underperform at Raymond James
11/09/21 Raymond James
Prospect Capital upgraded to Market Perform from Underperform at Raymond James
PSEC Prospect Capital
$6.78 /

-0.11 (-1.60%)

PSEC Prospect Capital
$6.78 /

-0.11 (-1.60%)

Hot Stocks
Prospect Capital announces launch of cash tender offer » 08:47
09/19/22
09/19
08:47
09/19/22
08:47
PSEC

Prospect Capital

$7.36 /

-0.055 (-0.74%)

Prospect Capital…

Prospect Capital announced that it has commenced a cash tender offer to purchase any and all of the outstanding notes listed below. The Tender Offer will expire at 5:00 p.m., New York City time, on September 23, 2022, or any other date and time to which the Company extends the Tender Offer. The Tender Offer is made pursuant to an Offer to Purchase dated today and related notice of guaranteed delivery, which set forth the terms and conditions of the Tender Offer. The consideration to be paid for each $1,000 principal amount of Notes that are validly tendered and not validly withdrawn on or prior to the Expiration Time is $980.00, plus accrued and unpaid interest on the Notes, if any, from the applicable last interest payment date up to, but not including, the Settlement Date. The Company will purchase any Notes that have been validly tendered at or prior to the Expiration Time and accepted for purchase, subject to all conditions to the Tender Offer having been either satisfied or waived by the Company, promptly following the Expiration Time. Assuming the Tender Offer is not extended, the Company expects that the Tender Offer will settle and payment will be made on September 28, 2022.

ShowHide Related Items >><<
PSEC Prospect Capital
$7.36 /

-0.055 (-0.74%)

PSEC Prospect Capital
$7.36 /

-0.055 (-0.74%)

11/09/21 Raymond James
Prospect Capital upgraded to Market Perform from Underperform at Raymond James
11/09/21 Raymond James
Prospect Capital upgraded to Market Perform from Underperform at Raymond James
PSEC Prospect Capital
$7.36 /

-0.055 (-0.74%)

PSEC Prospect Capital
$7.36 /

-0.055 (-0.74%)

Hot Stocks
Prospect Capital surpasses $1B preferred fundraising milestone » 07:13
09/09/22
09/09
07:13
09/09/22
07:13
PSEC

Prospect Capital

$7.50 /

+0.065 (+0.87%)

Prospect Capital…

Prospect Capital announced that Prospect's preferred stock offerings have exceeded $1B in aggregate liquidation preference issuances since the initial closing in the quarter ending December 31, 2020. The ongoing offering of the Series A1, M1, and M2 Preferred Stock being raised in the private wealth, institutional, and Registered Investment Advisor channels has approximately $645M now available for sale. In addition, on September 7, 2022, Prospect entered into an extension and upsizing of the revolving credit facility for Prospect Capital Funding, a GAAP consolidated and non-recourse subsidiary of Prospect, which will become effective on September 15, 2022, extends the term five years and the revolving period four years from such effective date, changes the interest rate on drawn amounts from one-month LIBOR plus 2.05% to one-month Term SOFR plus 2.05%, and increases the accordion feature, which allows the Facility, at Prospect's discretion, to accept additional commitments for up to a total of $2B of commitments. The Facility is increasing from $1.5B of commitments from 43 lenders to $1.584B of commitments from 44 lenders. Upon effectiveness of the extension, the Facility will mature on September 15, 2027 and will include a revolving period that extends through September 15, 2026, followed by an additional one-year amortization period.

ShowHide Related Items >><<
PSEC Prospect Capital
$7.50 /

+0.065 (+0.87%)

PSEC Prospect Capital
$7.50 /

+0.065 (+0.87%)

11/09/21 Raymond James
Prospect Capital upgraded to Market Perform from Underperform at Raymond James
11/09/21 Raymond James
Prospect Capital upgraded to Market Perform from Underperform at Raymond James
PSEC Prospect Capital
$7.50 /

+0.065 (+0.87%)

PSEC Prospect Capital
$7.50 /

+0.065 (+0.87%)

Earnings
Prospect Capital reports Q4 basic NII 21c, consensus 19c » 09:26
08/30/22
08/30
09:26
08/30/22
09:26
PSEC

Prospect Capital

$7.76 /

-0.05 (-0.64%)

Reports net asset value…

Reports net asset value per common share $10.48 vs. $10.81 last quarter. The company said, "We are unable to file our Annual Report on Form 10-K for the fiscal year ended June 30, 2022 within the prescribed time period without unreasonable effort or expense primarily because we require additional time to complete our assessment of the effectiveness of our internal control over financial reporting and our independent registered accounting firm requires additional time to complete its audit of our internal control over financial reporting...we expect to report a material weakness in our internal control over financial reporting relating to the operation of management review controls over the valuation of collateralized loan obligations ("CLOs"), including management's review procedures over the completeness and accuracy of the underlying data used in performing those review procedures. Additionally, we expect to report a material weakness relating to our control environment and monitoring activities; specifically, with respect to evaluating internal control deficiencies in a timely manner."

ShowHide Related Items >><<
PSEC Prospect Capital
$7.76 /

-0.05 (-0.64%)

PSEC Prospect Capital
$7.76 /

-0.05 (-0.64%)

11/09/21 Raymond James
Prospect Capital upgraded to Market Perform from Underperform at Raymond James
11/09/21 Raymond James
Prospect Capital upgraded to Market Perform from Underperform at Raymond James
PSEC Prospect Capital
$7.76 /

-0.05 (-0.64%)

PSEC Prospect Capital
$7.76 /

-0.05 (-0.64%)

Hot Stocks
Prospect Capital to delay release of 10-K; does not expect material impact » 09:24
08/30/22
08/30
09:24
08/30/22
09:24
PSEC

Prospect Capital

$7.76 /

-0.05 (-0.64%)

In a regulatory NT 10-K…

In a regulatory NT 10-K filing yesterday evening, the company stated: "Prospect Capital is unable to file its Annual Report on Form 10-K for the fiscal year ended June 30, 2022 within the prescribed time period without unreasonable effort or expense primarily because the Company requires additional time to complete its assessment of the effectiveness of its internal control over financial reporting and the Company's independent registered accounting firm requires additional time to complete its audit of the Company's internal control over financial reporting. Management is in the process of performing an assessment of the effectiveness of the Company's internal control over financial reporting as of June 30, 2022, based upon criteria in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission. Although the assessment is not yet complete, we expect to report a material weakness in our internal control over financial reporting relating to the operation of management review controls over the valuation of collateralized loan obligations, including management's review procedures over the completeness and accuracy of the underlying data used in performing those review procedures. Additionally, we expect to report a material weakness relating to our control environment and monitoring activities; specifically, with respect to evaluating internal control deficiencies in a timely manner. As a result of the foregoing, the Company needs additional time to finalize its financial statements and related disclosures to be filed as part of the 2022 Form 10-K. The Company expects to file its 2022 Form 10-K within the extension period of 15 calendar days as provided by Rule 12b-25 under the Securities Exchange Act of 1934, as amended. The Company anticipates that the material weaknesses described above will not require a fourth quarter 2022 adjustment or materially impact its consolidated financial statements for any prior annual or interim periods."

ShowHide Related Items >><<
PSEC Prospect Capital
$7.76 /

-0.05 (-0.64%)

PSEC Prospect Capital
$7.76 /

-0.05 (-0.64%)

11/09/21 Raymond James
Prospect Capital upgraded to Market Perform from Underperform at Raymond James
11/09/21 Raymond James
Prospect Capital upgraded to Market Perform from Underperform at Raymond James
PSEC Prospect Capital
$7.76 /

-0.05 (-0.64%)

PSEC Prospect Capital
$7.76 /

-0.05 (-0.64%)

Options
Prospect Capital options imply 2.8% move in share price post-earnings » 13:19
08/29/22
08/29
13:19
08/29/22
13:19
PSEC

Prospect Capital

$7.78 /

-0.03 (-0.38%)

Pre-earnings options…

Pre-earnings options volume in Prospect Capital is normal with calls leading puts 8:5. Implied volatility suggests the market is anticipating a move near 2.8%, or 22c, after results are released. Median move over the past eight quarters is 3.0%.

ShowHide Related Items >><<
PSEC Prospect Capital
$7.78 /

-0.03 (-0.38%)

PSEC Prospect Capital
$7.78 /

-0.03 (-0.38%)

11/09/21 Raymond James
Prospect Capital upgraded to Market Perform from Underperform at Raymond James
11/09/21 Raymond James
Prospect Capital upgraded to Market Perform from Underperform at Raymond James
PSEC Prospect Capital
$7.78 /

-0.03 (-0.38%)

PSEC Prospect Capital
$7.78 /

-0.03 (-0.38%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.